To the full analysis
Rentokil Initial stock: growth
RTORentokil Initial reported $6.91B in revenue for fiscal 2025, up 27.2% on the prior year, up 19.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.2%
per year from 2006 to 2025, per share 5.3%
Earnings (Annual rate)
3.5%
per year from 2006 to 2025, per share 1.6%
Free cash flow (Annual rate)
11.9%
per year from 2006 to 2025, per share 9.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 19.9% | 14.7% | 7.2% |
| Revenue per share | 12.7% | 11.0% | 5.3% |
| Earnings | 20.4% | 14.2% | 3.5% |
| Earnings per share | 13.7% | 10.8% | 1.6% |
| Free cash flow | 15.0% | 17.0% | 11.9% |
| Free cash flow per share | 8.1% | 13.2% | 9.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $1.84B | $245.1M | $91.4M |
| 2007 | $2.2B | $656.3M | −$50.4M |
| 2008 | $2.54B | $18.8M | −$36.8M |
| 2009 | $2.53B | $47.6M | $229.6M |
| 2010 | $2.5B | −$23.4M | $128.7M |
| 2011 | $2.54B | −$69.7M | $58.8M |
| 2012 | $2.23B | $47.6M | $59.8M |
| 2013 | $2.33B | $37.5M | $19.2M |
| 2014 | $1.74B | $126.1M | $95.1M |
| 2015 | $1.76B | $124.3M | $160.8M |
| 2016 | $2.17B | $167.5M | $175M |
| 2017 | $2.41B | $682.8M | $205.5M |
| 2018 | $2.47B | −$98.3M | $216.4M |
| 2019 | $2.71B | $283.8M | $322.4M |
| 2020 | $2.79B | $186M | $382.6M |
| 2021 | $2.95B | $263M | $407.2M |
| 2022 | $3.71B | $232M | $414M |
| 2023 | $5.38B | $381M | $526M |
| 2024 | $5.44B | $307M | $507M |
| 2025 | $6.91B | $470.44M | $769.72M |
Revenue by region
Where Rentokil Initial plc generates its revenue.
- United States61%
- Australia4%
- France3%
- Spain2%
- India1%
- Other30%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| United States | $3.22B | $3.18B | $4.18B | 60.5% |
| Australia | $181M | $194M | $252M | 3.6% |
| France | $380M | $392M | $186M | 2.7% |
| Spain | $72M | $76M | $110M | 1.6% |
| India | $59M | $68M | $93M | 1.3% |
| Other | $1.46B | $1.53B | $2.09B | 30.2% |
| Total revenue | $5.38B | $5.44B | $6.91B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 9 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.